Efficacy of Alpha-Blocker Add-on Therapy to Tadarafil Treated Men with Lower Urinary Tract Sympton

Trial Profile

Efficacy of Alpha-Blocker Add-on Therapy to Tadarafil Treated Men with Lower Urinary Tract Sympton

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Naftopidil (Primary) ; Silodosin (Primary)
  • Indications Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top